quinuclidines has been researched along with Esophageal Squamous Cell Carcinoma in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Doki, Y; Eguchi, H; Kobayashi, T; Kurokawa, Y; Makino, T; Morii, E; Nakajima, K; Saito, T; Takahashi, T; Tanaka, K; Yamasaki, M; Yamashita, K | 1 |
1 other study(ies) available for quinuclidines and Esophageal Squamous Cell Carcinoma
| Article | Year |
|---|---|
APR-246 induces apoptosis and enhances chemo-sensitivity via activation of ROS and TAp73-Noxa signal in oesophageal squamous cell cancer with TP53 missense mutation.
Topics: Animals; Apoptosis; Cell Line, Tumor; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Humans; Mice; Mutation, Missense; Proto-Oncogene Proteins c-bcl-2; Quinuclidines; Reactive Oxygen Species; Signal Transduction; Tumor Protein p73; Tumor Suppressor Protein p53; Up-Regulation; Xenograft Model Antitumor Assays | 2021 |